We are proud to announce that CytoVision has officially been conferred BioNexus Status, a prestigious recognition by Bioeconomy Corporation for biotechnology companies driving innovation, high-impact R&D, and national value creation.
๐งฌ ๐ช๐ต๐ผ ๐ถ๐ ๐๐๐๐ผ๐๐ถ๐๐ถ๐ผ๐ป?
Cytovision is a Malaysian digital pathology and AI technology company dedicated to transforming how pathology is practiced, accessed, and scaled.
Our core mission is to bridge the expertise gap, empower laboratories, and enable real-time telepathology, research, and AI-assisted diagnostics through advanced whole slide imaging and cloud-based solutions.
๐๏ธ ๐ช๐ต๐ฎ๐ ๐ถ๐ ๐๐ถ๐ผ๐ก๐ฒ๐ ๐๐ ๐ฆ๐๐ฎ๐๐๐?
BioNexus Status is a national endorsement granted to high-potential biotechnology companies that demonstrate:
โข Strong R&D foundations
โข Innovative and commercially scalable technologies
โข Meaningful contributions to Malaysiaโs bioeconomy and talent ecosystem
Receiving this status places Cytovision among a select group of companies recognized as strategic drivers for Malaysiaโs biotechnology growth.
๐ ๐ช๐ต๐ ๐๐๐๐ผ๐๐ถ๐๐ถ๐ผ๐ป ๐ช๐ฎ๐ ๐ฆ๐ฒ๐น๐ฒ๐ฐ๐๐ฒ๐ฑ
Cytovision was awarded BioNexus Status because of its pioneering work in digital pathology, including:
โข Developing EnvisionPath, an AI-enabled digital pathology platform that accelerates diagnosis, research, and education
โข Building on-demand telepathology services that connect laboratories with certified specialists
โข Advancing the adoption of high-throughput whole slide imaging technology across healthcare and research institutions
โข Supporting Malaysiaโs shift toward precision diagnostics, AI in medicine, and data-driven healthcare
๐ง ๐๐ป๐๐ถ๐๐ถ๐ผ๐ป๐ฃ๐ฎ๐๐ต ๐ฅ๐ฒ๐ฐ๐ผ๐ด๐ป๐ถ๐๐ฒ๐ฑ ๐๐ถ๐๐ต ๐ ๐๐ฆ๐ง๐ (๐ฎ๐ฌ๐ฎ๐ฑ)
Our flagship innovation, EnvisionPath, was granted MySTI Certification in 2025, signifying:
โข Proven technological originality
โข High potential for commercialisation
โข Strong prospects for export and global competitiveness
This milestone reinforces Cytovisionโs role in developing home-grown digital pathology technologies with international market potential.
We extend our heartfelt thanks to Bioeconomy Corporation, our collaborators, pathologists, universities, and hospital partners who continue to believe in our mission.
This is just the beginning.
Malaysiaโs digital pathology future is here โ and Cytovision is proud to lead the way.
hashtag#DigitalPathology hashtag#BioNexusStatus hashtag#Cytovision hashtag#AIinHealthcare hashtag#MySTI hashtag#BiotechnologyMalaysia hashtag#PrecisionDiagnostics hashtag#HealthTechMalaysia
